Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 1 |
2013 | 1 |
2014 | 2 |
2015 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.
J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):168-77. doi: 10.1097/QAI.0000000000000557.
J Acquir Immune Defic Syndr. 2015.
PMID: 26009829
Free PMC article.
Clinical Trial.
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.
Wyatt CM, Kitch D, Gupta SK, Tierney C, Daar ES, Sax PE, Ha B, Melbourne K, McComsey GA; AIDS Clinical Trials Group Study A5224s Team.
Wyatt CM, et al.
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):36-44. doi: 10.1097/QAI.0000000000000245.
J Acquir Immune Defic Syndr. 2014.
PMID: 25117929
Free PMC article.
Clinical Trial.
Item in Clipboard
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.
Jacobson JM, Wang H, Bordi R, Zheng L, Gross BH, Landay AL, Spritzler J, Routy JP, Benson C, Aberg J, Tebas P, Haas DW, Tiu J, Coughlin K, Purdue L, Sekaly RP; AIDS Clinical Trials Group (ACTG) A5212 Protocol Team.
Jacobson JM, et al.
J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):399-406. doi: 10.1097/QAI.0000000000000195.
J Acquir Immune Defic Syndr. 2014.
PMID: 24815851
Free PMC article.
Clinical Trial.
Item in Clipboard
Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.
Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Tebas P, Melbourne K, Ha B, Jahed NC, McComsey GA.
Erlandson KM, et al.
AIDS. 2013 Aug 24;27(13):2069-79. doi: 10.1097/QAD.0b013e328361d25d.
AIDS. 2013.
PMID: 24384588
Free PMC article.
Clinical Trial.
Item in Clipboard
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.
Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, de St Maurice AM, Currier JS, Williams PL.
Cohn SE, et al.
AIDS Care. 2011 Jun;23(6):775-85. doi: 10.1080/09540121.2010.525617.
AIDS Care. 2011.
PMID: 21293986
Free PMC article.
Item in Clipboard
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.
Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ; A5170 Study Team.
Robertson KR, et al.
Neurology. 2010 Apr 20;74(16):1260-6. doi: 10.1212/WNL.0b013e3181d9ed09. Epub 2010 Mar 17.
Neurology. 2010.
PMID: 20237308
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite